Connection | Profiles RNS

Search Result Details

This page shows the details of why an item matched the keywords from your search.

Search Results

Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.

One or more keywords matched the following properties of Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.

Property	Value
has minor subject area list	Age Factors; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; beta 2-Microglobulin; Cell Proliferation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epidemiologic Methods; Humans; Methotrexate; Middle Aged; Treatment Outcome; Vincristine

Search Criteria

Epidemiological Methods

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement